Drug major Ranbaxy Laboratories has received US health regulator's approval to market generic version of Novartis' Diovan tablets, used for treating high blood pressure and heart failure, in the US......
The US Food and Drug Administration has issued a warning letter to Ranbaxy Laboratories' American subsidiary Ohm Laboratories for violating current good manufacturing practice norms. "Ohm......
Shares of Ranbaxy Laboratories rose more than 5 per cent after the company announced a US regulatory approval for a hypertension drug to be launched by one of its subsidiaries. The stock rose by......
After its Paonta Sahib and Dewas units, Ranbaxy’s third and newly commissioned Mohali facility, too, appears to have come under the US regulator’s scanner. After finding deviations from......
Clean-up expands to US; Sun recalls 1 million units of anti-allergic drug made by Ranbaxy armSun Pharmaceutical Industries has initiated a recall of a little over a million boxes of Loratadine, an......